Hot topics in cell and gene therapy licensing agreements

Cell & Gene Therapy Partnering and Deal-Making – Where Now?

Novartis & Voyager Therapeutics inked a deal to develop gene therapies for Huntington’s and SMA

MaxCyte boss Doerfler excited by gene-editing licence deal

Pharma & Biotech M&A in Gene & Cell Therapy: What's Next in Advanced Therapeutics Deal Making?

Tapping into the potential commercial success of cell and gene therapies

Genprex forms global licensing deal with MD Anderson for its cancer drug Oncoprex

Revolutionizing Medicine: The Race to Unlock the Power of Gene Therapy and Build a Competitive Edge

Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals

Investment Trends in Europe’s Cell and Gene Therapy Sector

Panel: When Does Investing in Cell and Gene Therapy Make Business Sense?

Overcoming Raw Material Challenges in Cell and Gene Therapy Manufacturing

Masterclass: Partnering & Licensing

Innovative new licensing and M&A deals in healthtech

Delivering the Innovation of Gene Therapy to Patients Workshop

The Science Behind Gene Therapy

Planning for Cell & Gene Therapy Commercialization

FDA approves first gene therapy for sickle cell disease

Commercial and Regulatory Success in Accelerated Gene Therapy Development

Seelos Therapeutics acquires gene therapy program license to treat Parkinson's Disease